SWOG clinical trial number
SWOG-8217

Evaluation of Spirogermanium (NSC-192965) in Adenocarcinoma of the Prostate

Closed
Phase
Published
Abbreviated Title
Evaluation of Spirogermanium (NSC-192965) in Adenocarcinoma of the Prostate
Activated
08/11/1982
Closed
03/22/1985

Publication Information Expand/Collapse

1987

Phase II study of spirogermanium in advanced adenocarcinoma ofthe prostate: A Southwest Oncology Group study.

JH Saiers;B Blumenstein;M Slavik;JJ Costanzi;ED Crawford Cancer Treat Rep 71(12):1305-1306

1986

Spirogermanium in the treatment of stage D2 adenocarcinoma ofthe prostate: A Southwest Oncology Group study.

JH Saiers;M Slavik;J Costanzi;ED Crawford ASCO 5:111(#433)